4//SEC Filing
Flynn Paul R 4
Accession 0001093557-22-000181
CIK 0001093557other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:07 PM ET
Size
5.0 KB
Accession
0001093557-22-000181
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Flynn Paul R
EVP, Global Revenue
Transactions
- Sale
Common Stock
2022-12-08$123.50/sh−8,988$1,110,018→ 55,744 total
Footnotes (2)
- [F1]On September 9, 2022, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 55,744 unvested restricted stock units, 21,188 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 15,024 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,832 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850141
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:07 PM ET
- Size
- 5.0 KB